Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

HB 4167Session 2025-2026

Criminal procedure: sentencing guidelines; sentencing guidelines for illicit use of xylazine; provide for. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m).

House Introduced Bill

Underlined text would be added to current law. Struck-through text would be removed.

 

HOUSE BILL NO. 4167

A bill to amend 1927 PA 175, entitled

"The code of criminal procedure,"

by amending section 13m of chapter XVII (MCL 777.13m), as amended by 2016 PA 549.

the people of the state of michigan enact:


1

2

3

4


CHAPTER XVII

Sec. 13m. This chapter applies to the following felonies enumerated in chapter 333 of the Michigan Compiled Laws:

M.C.L.

Category

Class

Description

Stat Max


1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

333.7340

CS

F

Sale, distribution, or delivery of product containing ephedrine or pseudoephedrine by mail, internet, or telephone

4

333.7340c(2)

CS

D

Soliciting another person to purchase or obtain ephedrine or pseudoephedrine to manufacture methamphetamine

10

333.7341(8)

CS

G

Delivery or manufacture of imitation controlled substance

2

333.7401(2)(a)(i)

CS

A

Delivery or manufacture of 1,000 or more grams of certain schedule 1 or 2 controlled substances

Life

333.7401(2)(a)(ii)

CS

A

Delivery or manufacture of 450 or more but less than 1,000 grams of certain schedule 1 or 2 controlled substances

30


1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

333.7401(2)(a)(iii)

CS

B

Delivery or manufacture of 50 or more but less than 450 grams of certain schedule 1 or 2 controlled substances

20

333.7401(2)(a)(iv)

CS

D

Delivery or manufacture of less than 50 grams of certain schedule 1 or 2 controlled substances

20

333.7401(2)(b)(i)

CS

B

Delivery or manufacture of methamphetamine or 3, 4-methylenedioxymethamphetamine

20

333.7401(2)(b)(ii)

CS

E

Delivery or manufacture of certain schedule 1, 2, or 3 controlled substances

7

333.7401(2)(c)

CS

F

Delivery or manufacture of schedule 4 controlled substance

4


1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

333.7401(2)(d)(i)

CS

C

Delivery or manufacture of 45 or more kilograms of marihuana or synthetic equivalents of marihuana

15

333.7401(2)(d)(ii)

CS

D

Delivery or manufacture of 5 or more but less than 45 kilograms of marihuana or synthetic equivalents of marihuana

7

333.7401(2)(d)(iii)

CS

F

Delivery or manufacture of less than 5 kilograms or 20 plants of marihuana or synthetic equivalents of marihuana

4

333.7401(2)(e)

CS

G

Delivery or manufacture of schedule 5 controlled substance

2

333.7401(2)(f)

CS

D

Delivery or manufacture of a prescription form or counterfeit prescription form

7


1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

333.7401(2)(g)

CS

E

Delivery or manufacture of xylazine for illicit use

5

333.7401a

Person

B

Delivering a controlled substance or GBL with intent to commit criminal sexual conduct

20

333.7401b(3)(a)

CS

E

Delivery or manufacture of GBL

7

333.7401b(3)(b)

CS

G

Possession of GBL

2

333.7401c(2)(a)

CS

D

Operating or maintaining controlled substance laboratory

10

333.7401c(2)(b)

CS

B

Operating or maintaining controlled substance laboratory in presence of minor

20

333.7401c(2)(c)

CS

B

Operating or maintaining controlled substance laboratory involving hazardous waste

20

333.7401c(2)(d)

CS

B

Operating or maintaining controlled substance laboratory near certain places

20


1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

333.7401c(2)(e)

CS

A

Operating or maintaining controlled substance laboratory involving firearm or other harmful device

25

333.7401c(2)(f)

CS

B

Operating or maintaining controlled substance laboratory involving methamphetamine

20

333.7402(2)(a)

CS

D

Delivery or manufacture of certain counterfeit controlled substances

10

333.7402(2)(b)

CS

E

Delivery or manufacture of schedule 1, 2, or 3 counterfeit controlled substance

5

333.7402(2)(c)

CS

F

Delivery or manufacture of counterfeit schedule 4 controlled substance

4

333.7402(2)(d)

CS

G

Delivery or manufacture of counterfeit schedule 5 controlled substance

2


1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

333.7402(2)(e)

CS

C

Delivery or manufacture of controlled substance analogue

15

333.7403(2)(a)(i)

CS

A

Possession of 1,000 or more grams of certain schedule 1 or 2 controlled substances

Life

333.7403(2)(a)(ii)

CS

A

Possession of 450 or more but less than 1,000 grams of certain schedule 1 or 2 controlled substances

30

333.7403(2)(a)(iii)

CS

B

Possession of 50 or more but less than 450 grams of certain schedule 1 or 2 controlled substances

20

333.7403(2)(a)(iv)

CS

G

Possession of 25 or more but less than 50 grams of certain schedule 1 or 2 controlled substances

4

333.7403(2)(a)(v)

CS

G

Possession of less than 25 grams of certain schedule 1 or 2 controlled substances

4


1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

333.7403(2)(b)(i)

CS

D

Possession of methamphetamine or 3, 4-methylenedioxymethamphetamine

10

333.7403(2)(b)(ii)

CS

G

Possession of certain schedule 1, 2, 3, or 4 controlled substances or controlled substances analogue

2

333.7403(2)(f)

CS

E

Possession of xylazine for illicit use

5

333.7403a 333.7403a(4)(a)

CS

F

Fraudulently obtaining controlled substance or prescription for controlled substance

4

333.7403a(4)(b)

CS

E

Fraudulently obtaining xylazine for illicit use

5

333.7405(1)(a)

CS

G

Controlled substance violations by licensee

2

333.7405(1)(b)

CS

G

Manufacturing or distribution violations by licensee

2

333.7405(1)(c)

CS

G

Refusing lawful inspection

2

333.7405(1)(d)

CS

G

Maintaining drug house

2


1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

333.7405(1)(e)

CS

G

Unlawfully dispensing out-of-state prescription

2

333.7407(1)(a)

CS

G

Controlled substance violations by licensee

4

333.7407(1)(b)

CS

G

Use of fictitious, revoked, or suspended license number

4

333.7407(1)(c)

CS

G

Obtaining controlled substance by fraud

4

333.7407(1)(d)

CS

G

False reports under controlled substance article

4

333.7407(1)(e)

CS

G

Possession of counterfeiting implements

4

333.7407(1)(f)

CS

F

Disclosing or obtaining prescription informationPossession of a counterfeit prescription form

4

333.7407(1)(g)

CS

F

Possession of counterfeit prescription form

4

333.7407(2)

CS

G

Refusing to furnish records under controlled substance article

4


1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

333.7410a

CS

G

Controlled substance offense or offense involving GBL in or near a park

2

333.7417

CS

F

Sell or offer to sell named product producing same or similar effect as scheduled ingredient

4

333.7455(1)(a)

CS

E

Sell or offer to sell certain objects for the illicit use of xylazine

5

Enacting section 1. This amendatory act does not take effect unless House Bill No. 4166 (request no. H00979'25) of the 103rd Legislature is enacted into law.

Official text from the Michigan Legislature. Formatting has been adapted for reading on Ratifi.